These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36389018)

  • 41. Telomere length across different UIP fibrotic-Interstitial Lung Diseases: a prospective Greek case-control study.
    Tomos I; Karakatsani A; Manali ED; Kottaridi C; Spathis A; Argentos S; Papiris SA
    Pulmonology; 2022; 28(4):254-261. PubMed ID: 33358512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.
    Teramachi R; Kondoh Y; Kataoka K; Taniguchi H; Matsuda T; Kimura T; Yokoyama T; Yamano Y; Furukawa T; Sakamoto K; Hashimoto N; Hasegawa Y
    Respir Med; 2018 Oct; 143():147-152. PubMed ID: 30261987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis.
    Kakugawa T; Yokota S; Ishimatsu Y; Hayashi T; Nakashima S; Hara S; Sakamoto N; Kubota H; Mine M; Matsuoka Y; Mukae H; Nagata K; Kohno S
    Cell Stress Chaperones; 2013 Sep; 18(5):581-90. PubMed ID: 23435730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Weng D; Chen XQ; Qiu H; Zhang Y; Li QH; Zhao MM; Wu Q; Chen T; Hu Y; Wang LS; Wei YR; Du YK; Chen SS; Zhou Y; Zhang F; Shen L; Su YL; Kolb M; Li HP
    Mediators Inflamm; 2019; 2019():5160694. PubMed ID: 30718973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: a retrospective single-centre study.
    Ikuyama Y; Ushiki A; Kosaka M; Akahane J; Mukai Y; Araki T; Kitaguchi Y; Tateishi K; Urushihata K; Yasuo M; Yamamoto H; Hanaoka M
    BMC Pulm Med; 2020 May; 20(1):144. PubMed ID: 32434532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
    Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
    Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spliceosome-associated protein 130: a novel biomarker for idiopathic pulmonary fibrosis.
    Liu K; Liu D; Feng Y; Zhang H; Zeng D; Liu Q; Qu J
    Ann Transl Med; 2020 Aug; 8(16):986. PubMed ID: 32953786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias.
    Arai T; Tachibana K; Sugimoto C; Inoue Y; Tokura S; Okuma T; Akira M; Kitaichi M; Hayashi S; Inoue Y
    Respirology; 2017 Oct; 22(7):1363-1370. PubMed ID: 28508494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
    Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
    Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial.
    Hailong Z; Jiansheng L; Wen G; Lu W; Dong Z; Limin Z; Miao Z; Weixian L
    Trials; 2022 Feb; 23(1):103. PubMed ID: 35109889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Humoral Immune Status in Relation to Outcomes in Patients with Idiopathic Pulmonary Fibrosis.
    Hoffman TW; van Moorsel CHM; Kazemier KM; Biesma DH; Grutters JC; van Kessel DA
    Lung; 2021 Dec; 199(6):667-676. PubMed ID: 34714393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
    Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
    Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
    Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis.
    Tomos I; Dimakopoulou K; Manali ED; Papiris SA; Karakatsani A
    Environ Health; 2021 Aug; 20(1):99. PubMed ID: 34461906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exposure to PM
    Tahara M; Fujino Y; Yamasaki K; Oda K; Kido T; Sakamoto N; Kawanami T; Kataoka K; Egashira R; Hashisako M; Suzuki Y; Fujisawa T; Mukae H; Suda T; Yatera K
    Respir Res; 2021 Mar; 22(1):80. PubMed ID: 33711988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
    Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
    Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.